• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Palliative care services are underutilized at end of life in Ontario, Canada

byJayden BerdugoandAlex Chan
March 7, 2024
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In Ontario Canada, only 50% of home care clients received at least 1 or more palliative home care visits during their last 6 months of life.

2. The Risk Evaluation for Support: Predictions for Elder-life in their Communities Tool (RESPECT) served as a valuable prognostic model to provide early identification of palliative care needs.

 Evidence Rating Level: 2 (Good)

Palliative care is as essential service in the provision of holistic and patient-centred care for those diagnosed with life-limiting illnesses. Earlier initiation of palliative care has been linked with better outcomes such as improved quality of life and reduced distress. Despite this however, there is evidence that in Canada, as little as 15% of eligible individuals receive palliative care in their last year of life. This retrospective cohort study involved individuals 50 years or older (median age 80.1 [SD 11.0) years, mostly female [61.9%]) and examined their use of health care in Ontario. Within the first 6 months of the study, 29420 (11.9%) of the participants died. The median survival ranged from 30 days to 1576 days, and 98.1% in RESPECT risk bin 1 to 1.6% in risk bin 61. Only a few participants (2.6%) that were receiving home care, received a diagnosis of end-stage disease. The median survival was 58 (Interquartile range [IQR] 19-181) days for individuals with a median survival of less than 3 months, whereas the median survival for those predicted to live between 3 to 6 months was 144 (IQR 47-466) days, and 268 (IQR 79-826) days for those with a predicted median survival between 6 to 12 months. In all, this study corroborates prior literature that there is a poor utilization rate of palliative care resources in Canada.

Click to read the study in CMAJ

Image: PD

RELATED REPORTS

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

New Mexico measles outbreak associated with significant costs

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: end-of-lifehome careoncologypalliative carepublic health
Previous Post

Including e-cigarettes in smoking cessation counseling increases tobacco abstinence

Next Post

Mindfulness-Based Interventions May Be Comparable to Cognitive Behavioural Therapy At Improving ADHD-related Symptoms

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

August 3, 2026
Epidemiologic features of the 2018-2019 measles outbreak in New York City
Infectious Disease

New Mexico measles outbreak associated with significant costs

August 2, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026
Next Post
AAP recommends focus on nutrient-rich foods in schools

Mindfulness-Based Interventions May Be Comparable to Cognitive Behavioural Therapy At Improving ADHD-related Symptoms

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

Blood type correlates with egg reserve in infertile women

Elafibranor associated with biochemical response in patients with primary biliary cholangitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Brain-predicted age difference may reliably predict dementia progression
  • Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage
  • A neurostimulation intervention may improve pain in patients with chronic low back pain
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.